Involvement of the protein kinase C pathway in thyrotropin-induced STAT3 activation in FRTL-5 thyroid cells

Y J Park1, E S Park, M S Kim

  • 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, 28 Yongon-dong Chongno-gu, 110-744 Seoul, South Korea.

Insights

Thyrotropin (TSH) activates STAT3 through the TSH receptor. This study reveals that both cyclic AMP (cAMP) and protein kinase C (PKC) pathways are involved in TSH-induced STAT3 activation.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Signaling

Background:

  • Thyrotropin (TSH) binding to its receptor (TSHR) activates cAMP-protein kinase A (PKA) and protein kinase C (PKC) pathways.
  • TSH also activates the Janus kinases (JAK)/signal transducer and activator of transcription (STAT) pathway via TSHR.

Purpose of the Study:

  • To investigate the involvement of cAMP/PKA or PKC systems in STAT3 activation by TSH.
  • To elucidate the signaling mechanisms downstream of TSHR activation.

Main Methods:

  • TSH treatment of FRTL-5 thyrocytes and human TSHR-expressing CHO cells.
  • Inhibition studies using a blocking antibody against TSHR, PKA inhibitors, and PKC inhibitors.
  • Assessment of STAT3 phosphorylation as a marker of activation.

Main Results:

  • TSH treatment led to STAT3 phosphorylation in both cell types.
  • TSH-induced STAT3 activation was blocked by a TSHR antibody.
  • Increased intracellular cAMP activated STAT3, but PKA inhibition did not affect it.
  • PKC activation (PMA) induced STAT3 phosphorylation, and PKC inhibitors blocked this.
  • PKC inhibition also blocked STAT3 activation induced by cAMP stimulation.

Conclusions:

  • TSH activates STAT3 via TSHR through both cAMP- and PKC-dependent pathways.
  • Protein kinase C (PKC) appears to be involved in the signaling pathway downstream of cAMP in response to TSH.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...